HRP20190509T1 - Spoj piridilaminooctene kiseline - Google Patents
Spoj piridilaminooctene kiselineInfo
- Publication number
- HRP20190509T1 HRP20190509T1 HRP20190509TT HRP20190509T HRP20190509T1 HR P20190509 T1 HRP20190509 T1 HR P20190509T1 HR P20190509T T HRP20190509T T HR P20190509TT HR P20190509 T HRP20190509 T HR P20190509T HR P20190509 T1 HRP20190509 T1 HR P20190509T1
- Authority
- HR
- Croatia
- Prior art keywords
- acid compound
- pyridylaminoacetic acid
- pyridylaminoacetic
- compound
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008062926 | 2008-03-12 | ||
| EP09721163.5A EP2264009B1 (en) | 2008-03-12 | 2009-03-12 | Pyridylaminoacetic acid compound |
| PCT/JP2009/054713 WO2009113600A1 (ja) | 2008-03-12 | 2009-03-12 | ピリジルアミノ酢酸化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20190509T1 true HRP20190509T1 (hr) | 2019-05-03 |
Family
ID=41065261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20190509TT HRP20190509T1 (hr) | 2008-03-12 | 2019-03-14 | Spoj piridilaminooctene kiseline |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8648097B2 (hr) |
| EP (1) | EP2264009B1 (hr) |
| JP (3) | JP5136640B2 (hr) |
| KR (1) | KR101609001B1 (hr) |
| CN (2) | CN103965099A (hr) |
| AU (1) | AU2009224329B2 (hr) |
| CA (1) | CA2718393C (hr) |
| CY (1) | CY1121543T1 (hr) |
| DK (1) | DK2264009T3 (hr) |
| ES (1) | ES2718813T3 (hr) |
| HR (1) | HRP20190509T1 (hr) |
| HU (1) | HUE042839T2 (hr) |
| LT (1) | LT2264009T (hr) |
| PL (1) | PL2264009T3 (hr) |
| PT (1) | PT2264009T (hr) |
| SI (1) | SI2264009T1 (hr) |
| TR (1) | TR201904655T4 (hr) |
| WO (1) | WO2009113600A1 (hr) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2264009T3 (en) * | 2008-03-12 | 2019-04-15 | Ube Industries | PYRIDYLAMINE ACEDIC ACID COMPOUND |
| SI2415763T1 (sl) * | 2009-03-30 | 2016-05-31 | Ube Industries, Ltd. | Farmacevtski sestavek za zdravljenje ali preprečevanje glavkoma |
| WO2011030871A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | Ｎ－置換ヘテロアリール化合物 |
| WO2011030873A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | ベンジル化合物 |
| JP2011057633A (ja) * | 2009-09-11 | 2011-03-24 | Ube Industries Ltd | ピリジルアミノ酢酸化合物を含有する医薬 |
| EP2476678A4 (en) * | 2009-09-11 | 2013-02-20 | Ube Industries | SUBSTITUTED CARBONYL COMPOUNDS |
| WO2011030865A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | 置換ベンジル化合物 |
| WO2011030872A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | スルホンアミド化合物 |
| EP2476668B1 (en) * | 2009-09-11 | 2013-11-06 | Ube Industries, Ltd. | Aniline compounds |
| CA2785668A1 (en) * | 2009-12-25 | 2011-06-30 | Ube Industries, Ltd. | Aminopyridine compound |
| WO2011111831A1 (ja) * | 2010-03-12 | 2011-09-15 | 日本曹達株式会社 | ピリジン環含有化合物、及びハロゲン化ピコリン誘導体及びテトラゾリルオキシム誘導体の製造方法 |
| WO2011113861A2 (de) | 2010-03-18 | 2011-09-22 | Bayer Cropscience Ag | Aryl- und hetarylsulfonamide als wirkstoffe gegen abiotischen pflanzenstress |
| EP2471363A1 (de) | 2010-12-30 | 2012-07-04 | Bayer CropScience AG | Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen |
| CN105308023A (zh) * | 2013-03-28 | 2016-02-03 | 宇部兴产株式会社 | 取代联芳基化合物 |
| TW201542525A (zh) * | 2013-09-02 | 2015-11-16 | Ube Industries | 肺疾患的治療及／或預防用的醫藥組成物 |
| MX2020003133A (es) | 2014-01-10 | 2021-08-23 | Santen Pharmaceutical Co Ltd | Composicion farmaceutica que contiene compuesto de acido piridilaminoacetico. |
| KR101824829B1 (ko) | 2014-01-10 | 2018-02-01 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물을 포함하는 의약 제제 |
| GEP20186916B (en) | 2014-01-10 | 2018-11-12 | Pharmaceutical Co Ltd Santen | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
| US10774072B2 (en) * | 2014-06-10 | 2020-09-15 | Ube Industries, Ltd. | Crystal of N-substituted sulfonamide compound |
| CA2951784C (en) | 2014-06-10 | 2022-05-31 | Ube Industries, Ltd. | N-substituted sulfonamide compound and method for producing same |
| US10519112B2 (en) | 2014-06-10 | 2019-12-31 | Ube Industries, Ltd. | Method for producing heteroaromatic sulfonamide compound |
| JP2017206445A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 呼吸器疾患の治療及び／又は予防のための医薬組成物 |
| JP2017206443A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 置換ビアリール化合物及び他の医薬の組み合わせ |
| EP3320904B1 (en) | 2015-07-09 | 2023-07-05 | Santen Pharmaceutical Co., Ltd. | Preventative and/or therapeutic agent containing pyridyl aminoacetic acid compound for treating a disease involving a greatly elevated intraocular pressure |
| WO2018108627A1 (de) | 2016-12-12 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Verwendung substituierter indolinylmethylsulfonamide oder deren salze zur steigerung der stresstoleranz in pflanzen |
| WO2019025153A1 (de) | 2017-07-31 | 2019-02-07 | Bayer Cropscience Aktiengesellschaft | Verwendung von substituierten n-sulfonyl-n'-aryldiaminoalkanen und n-sulfonyl-n'-heteroaryldiaminoalkanen oder deren salzen zur steigerung der stresstoleranz in pflanzen |
| WO2019065838A1 (ja) | 2017-09-29 | 2019-04-04 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含有する医薬 |
| KR20200103041A (ko) | 2017-12-21 | 2020-09-01 | 산텐 세이야꾸 가부시키가이샤 | 오미데네팍의 조합 |
| KR20200103719A (ko) | 2017-12-28 | 2020-09-02 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물을 함유하는 의약 제제 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06509211A (ja) | 1990-06-08 | 1994-10-13 | エスピーエス・テクノロジーズ・インコーポレーテッド | 改良磁性材料及びその製造方法 |
| TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
| UA59384C2 (uk) | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
| UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
| ZA99607B (en) | 1998-01-27 | 1999-07-27 | Rhone Poulenc Rorer Pharma | Substituted oxoazaheterocyclyl factor xa inhibitors. |
| WO2002024647A1 (fr) | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
| IL160253A0 (en) * | 2001-08-09 | 2004-07-25 | Ono Pharmaceutical Co | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
| DE60118628T2 (de) | 2001-10-26 | 2007-02-15 | Allergan, Inc., Irvine | Omega-cycloalkyl 17-heteroaryl prostaglandin e2 analogen als ep2-rezeptor agonisten |
| MXPA04004960A (es) * | 2002-01-31 | 2005-04-08 | Pfizer Prod Inc | METABOLITOS DEL áCIDO (3-{[4- TERC-BUTILBENCIL) -(PIRIDIN-3- SULFONIL) AMINO]METIL} FENOXI) ACETICO. |
| AU2003211574A1 (en) * | 2002-03-05 | 2003-09-16 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| WO2004078169A1 (en) * | 2003-03-04 | 2004-09-16 | Pfizer Products Inc. | Use of ep2 selective receptor agonists in medical treatment |
| GB0329620D0 (en) | 2003-12-22 | 2004-01-28 | Pharmagene Lab Ltd | EP2 receptor agonists |
| WO2005072743A1 (ja) | 2004-01-30 | 2005-08-11 | Ono Pharmaceutical Co., Ltd. | 気管支拡張剤 |
| JP2007186424A (ja) | 2004-11-26 | 2007-07-26 | Ono Pharmaceut Co Ltd | 気管支拡張剤 |
| JP4734119B2 (ja) | 2004-02-12 | 2011-07-27 | 田辺三菱製薬株式会社 | インダゾール化合物及びその医薬用途 |
| EP1593671A1 (en) | 2004-03-05 | 2005-11-09 | Graffinity Pharmaceuticals AG | DPP-IV inhibitors |
| US20060135773A1 (en) | 2004-06-17 | 2006-06-22 | Semple Joseph E | Trisubstituted nitrogen modulators of tyrosine phosphatases |
| GB0415320D0 (en) * | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| CA2593439C (en) | 2005-01-14 | 2014-02-25 | F. Hoffmann-La Roche Ag | Thiazole-4-carboxamide derivatives as mglur5 antagonists |
| JP4874958B2 (ja) | 2005-03-30 | 2012-02-15 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピリジン誘導体を含有する抗真菌剤 |
| AU2006275263A1 (en) | 2005-08-03 | 2007-02-08 | Merck Frosst Canada Ltd | EP4 receptor agonist, compositions and methods thereof |
| CA2618486A1 (en) * | 2005-08-09 | 2007-02-15 | Asterand Uk Limited | Ep2 receptor agonists |
| US7696235B2 (en) * | 2005-08-29 | 2010-04-13 | Allergan, Inc. | EP2 receptor agonists for treating glaucoma |
| CN101495452B (zh) * | 2006-07-28 | 2012-04-25 | 辉瑞产品公司 | Ep2激动剂 |
| JP4583500B2 (ja) * | 2006-07-28 | 2010-11-17 | ファイザー・プロダクツ・インク | Ｅｐ２作動薬 |
| DK2264009T3 (en) | 2008-03-12 | 2019-04-15 | Ube Industries | PYRIDYLAMINE ACEDIC ACID COMPOUND |
| SI2415763T1 (sl) * | 2009-03-30 | 2016-05-31 | Ube Industries, Ltd. | Farmacevtski sestavek za zdravljenje ali preprečevanje glavkoma |
-
2009
- 2009-03-12 DK DK09721163.5T patent/DK2264009T3/en active
- 2009-03-12 LT LTEP09721163.5T patent/LT2264009T/lt unknown
- 2009-03-12 HU HUE09721163A patent/HUE042839T2/hu unknown
- 2009-03-12 WO PCT/JP2009/054713 patent/WO2009113600A1/ja active Application Filing
- 2009-03-12 EP EP09721163.5A patent/EP2264009B1/en active Active
- 2009-03-12 CN CN201410213200.5A patent/CN103965099A/zh active Pending
- 2009-03-12 SI SI200931953T patent/SI2264009T1/sl unknown
- 2009-03-12 AU AU2009224329A patent/AU2009224329B2/en active Active
- 2009-03-12 KR KR1020107022680A patent/KR101609001B1/ko active IP Right Grant
- 2009-03-12 ES ES09721163T patent/ES2718813T3/es active Active
- 2009-03-12 JP JP2010502864A patent/JP5136640B2/ja active Active
- 2009-03-12 CN CN200980108500.4A patent/CN101970410B/zh active Active
- 2009-03-12 PT PT09721163T patent/PT2264009T/pt unknown
- 2009-03-12 PL PL09721163T patent/PL2264009T3/pl unknown
- 2009-03-12 US US12/922,028 patent/US8648097B2/en active Active
- 2009-03-12 TR TR2019/04655T patent/TR201904655T4/tr unknown
- 2009-03-12 CA CA2718393A patent/CA2718393C/en active Active
-
2012
- 2012-11-15 JP JP2012251011A patent/JP5545344B2/ja not_active Expired - Fee Related
-
2013
- 2013-12-16 US US14/108,029 patent/US20140113907A1/en not_active Abandoned
-
2014
- 2014-05-14 JP JP2014100287A patent/JP2014177476A/ja active Pending
-
2019
- 2019-03-14 HR HRP20190509TT patent/HRP20190509T1/hr unknown
- 2019-03-28 CY CY20191100359T patent/CY1121543T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013063994A (ja) | 2013-04-11 |
| JP5545344B2 (ja) | 2014-07-09 |
| LT2264009T (lt) | 2019-04-25 |
| PL2264009T3 (pl) | 2019-07-31 |
| US20110054172A1 (en) | 2011-03-03 |
| HUE042839T2 (hu) | 2019-07-29 |
| CN101970410A (zh) | 2011-02-09 |
| CY1121543T1 (el) | 2020-05-29 |
| CN103965099A (zh) | 2014-08-06 |
| AU2009224329A1 (en) | 2009-09-17 |
| DK2264009T3 (en) | 2019-04-15 |
| JP2014177476A (ja) | 2014-09-25 |
| WO2009113600A1 (ja) | 2009-09-17 |
| JP5136640B2 (ja) | 2013-02-06 |
| PT2264009T (pt) | 2019-04-29 |
| EP2264009A4 (en) | 2012-08-01 |
| KR101609001B1 (ko) | 2016-04-04 |
| AU2009224329B2 (en) | 2013-11-07 |
| CN101970410B (zh) | 2014-06-25 |
| US8648097B2 (en) | 2014-02-11 |
| KR20100123903A (ko) | 2010-11-25 |
| CA2718393A1 (en) | 2009-09-17 |
| JPWO2009113600A1 (ja) | 2011-07-21 |
| TR201904655T4 (tr) | 2019-06-21 |
| EP2264009B1 (en) | 2019-03-06 |
| SI2264009T1 (sl) | 2019-05-31 |
| ES2718813T3 (es) | 2019-07-04 |
| US20140113907A1 (en) | 2014-04-24 |
| CA2718393C (en) | 2015-06-16 |
| EP2264009A1 (en) | 2010-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190509T1 (hr) | Spoj piridilaminooctene kiseline | |
| HK1153453A1 (en) | Carboxylic acid compound | |
| GB0818033D0 (en) | Novel compound | |
| HK1226051A1 (zh) | 14-羥基-二十二烯酸化合物 | |
| EP2192109A4 (en) | BICYCLIC AMINO ACID DERIVATIVE | |
| GB0800035D0 (en) | Compounds | |
| GB0804989D0 (en) | Compound | |
| ZA201000869B (en) | Phenylacetic acid compound | |
| EP2284159A4 (en) | 5-hydroxypyrimidine-4-carboxamide compound | |
| GB0803494D0 (en) | Compound | |
| IL206524A0 (en) | 4-dimethylminobutyric acid derivatives | |
| GB0800367D0 (en) | Compounds | |
| IL207035A0 (en) | Benzylpiperizine compound | |
| GB0823316D0 (en) | Compound | |
| GB0820918D0 (en) | Compound | |
| GB0802227D0 (en) | Compound | |
| GB0820916D0 (en) | Compound | |
| GB0820915D0 (en) | Compound | |
| GB0820249D0 (en) | Compound | |
| GB0812580D0 (en) | Compound | |
| GB0822635D0 (en) | Compound | |
| GB0815806D0 (en) | Compound | |
| GB0802193D0 (en) | Compound | |
| GB0820919D0 (en) | Compound | |
| GB0805430D0 (en) | Compound |